Wonbiogen Co., Ltd. (KOSDAQ: 307280)

Wonbiogen Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	40,971	60,375	58,397	74,002	-
Market Cap Growth	-17.85%	3.39%	-21.09%	-	-
Enterprise Value	33,407	60,117	59,424	68,665	-
Last Close Price	1155.00	1672.37	1620.80	1958.43	-
PE Ratio	8.14	10.98	18.21	-	-
Forward PE	-	5.79	-	-	-
PS Ratio	1.40	2.04	2.18	4.18	-
PB Ratio	1.15	1.85	2.18	2.79	-
P/TBV Ratio	1.41	1.93	2.25	2.87	-
P/FCF Ratio	6.13	18.93	-	-	-
P/OCF Ratio	6.22	12.49	10.10	68.39	-
EV/Sales Ratio	1.14	2.03	2.22	3.87	-
EV/EBITDA Ratio	4.13	6.98	9.51	23.51	-
EV/EBIT Ratio	5.18	8.54	11.77	33.66	-
EV/FCF Ratio	4.99	18.85	-	-	-
Debt / Equity Ratio	0.18	0.22	0.34	0.30	-3.70
Debt / EBITDA Ratio	0.81	0.85	1.47	2.77	0.83
Debt / FCF Ratio	0.98	2.29	-	-	22.63
Asset Turnover	0.68	0.72	0.69	0.62	-
Inventory Turnover	2.26	2.40	2.66	2.96	-
Quick Ratio	2.15	1.45	1.03	1.61	0.29
Current Ratio	2.92	2.26	1.57	2.10	0.42
Return on Equity (ROE)	16.39%	20.05%	12.26%	-5.11%	-
Return on Assets (ROA)	9.37%	10.75%	8.20%	4.45%	-
Return on Capital (ROIC)	10.05%	11.58%	8.93%	6.96%	-
Earnings Yield	12.29%	9.11%	5.49%	-0.97%	-
FCF Yield	16.32%	5.28%	-1.22%	-1.69%	-
Dividend Yield	1.72%	1.20%	0.62%	-	-
Payout Ratio	13.17%	6.36%	-	-	-
Buyback Yield / Dilution	-1.44%	-5.70%	-3.58%	-49.52%	-
Total Shareholder Return	0.28%	-4.50%	-2.96%	-49.52%	-

Source: S&P Capital IQ. Standard template. Financial Sources.